Inscobee Attempts Hostile Board Takeover of Apimeds Pharmaceuticals Merger Counterpart MindWave Innovations

Otsuka Pharmaceutical Acquires Mindset Pharma

August 31, 2023

Biotechnology

Otsuka Pharmaceutical Co., Ltd., through its wholly owned U.S. subsidiary Otsuka America, Inc., agreed to acquire Mindset Pharma Inc. in an all-cash statutory plan of arrangement valued at approximately CAD 80 million. The acquisition adds Mindset’s next-generation psychedelic and non-psychedelic drug discovery assets and synthesis capabilities to Otsuka’s psychiatry and neurology pipeline.

Numinus Wellness Inc. Acquires Novamind Inc.

April 12, 2022

Healthcare Services

Numinus Wellness Inc. agreed to acquire all issued and outstanding common shares of Novamind Inc. in an all‑share, court‑approved plan of arrangement valued at approximately C$26.2 million (fully diluted). The deal, expected to close in June 2022, creates a combined operator with 13 wellness clinics, approximately C$10 million in pro‑forma annual revenue, and an expected C$3 million in annual cost synergies.

Mobeus Backs £25.5m MBO of Inbox Insight

January 7, 2022

Marketing & Advertising

Mobeus has backed a £25.5 million management buyout (MBO) of Inbox Insight with a £17.7 million equity investment, alongside vendor and management rollover. Inbox Insight, a UK-headquartered B2B demand generation and content syndication agency with offices in the UK, US and South Africa, will continue under incumbent MD Jamie Hendrie and use the investment to accelerate technology, data science and US growth.

Quantum Surgical Acquires NeuWave Medical

February 27, 2026

Medical Devices

Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.

Pacific Software Inc. (PurMinds Enterprises) Completes RTO Acquisition of PurMinds Holdings Inc.

November 3, 2025

Biotechnology

Pacific Software, Inc. completed a change of control and reverse takeover (RTO) transaction with PurMinds Holdings Inc., finalizing the acquisition effective November 3, 2025 and rebranding the public company as PurMinds Enterprises, Inc. The combined company has taken occupancy of a 20,477 sq. ft. cGMP-ready pharmaceutical manufacturing and R&D facility and is pursuing OTCQX uplisting and PCAOB-audited financials to support its clinical-stage neuromedicine strategy.

Bruker Corporation Acquires Inscopix, Inc.

November 8, 2022

Medical Devices

Bruker Corporation has acquired Inscopix, Inc., a Mountain View–based developer of miniaturized head-mounted microscopes (miniscopes) for freely moving animal brain imaging. The acquisition integrates Inscopix’s miniscope platform and analysis pipeline with Bruker’s preclinical imaging and multiphoton microscopy capabilities to expand Bruker’s in-vivo neural functional imaging offerings; financial terms were not disclosed.